Skip to content
10-Q

Quarterly Report

Instil Bio, Inc. TIL

0001789769-26-000045

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 13, 2026 6.78M sh
Shares Diluted Q1 2026 · Mar 31, 2026 6.78M sh
Shares Diluted Q1 2026 · Mar 31, 2025 6.53M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$1.34M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$4.2M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $5.02M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $6.64M
Stockholders Equity Q1 2026 · Mar 31, 2026 $110.7M
Stockholders Equity Q1 2026 · Dec 31, 2025 $113.87M
Stockholders Equity Q1 2026 · Mar 31, 2025 $144.91M
Stockholders Equity Q1 2026 · Dec 31, 2024 $169.44M
Current Liabilities Q1 2026 · Mar 31, 2026 $4.72M
Current Liabilities Q1 2026 · Dec 31, 2025 $4.84M
Total Liabilities Q1 2026 · Mar 31, 2026 $89.73M
Total Liabilities Q1 2026 · Dec 31, 2025 $89.66M
Current Assets Q1 2026 · Mar 31, 2026 $188.3M
Current Assets Q1 2026 · Dec 31, 2025 $191.43M
Total Assets Q1 2026 · Mar 31, 2026 $200.43M
Total Assets Q1 2026 · Dec 31, 2025 $203.52M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.62
Eps Diluted Q1 2026 · Mar 31, 2025 −$4.32
Eps Basic Q1 2026 · Mar 31, 2026 −$0.62
Eps Basic Q1 2026 · Mar 31, 2025 −$4.32
Sga Expense Q1 2026 · Mar 31, 2026 $5.35M
Sga Expense Q1 2026 · Mar 31, 2025 $9.11M
Net Income Q1 2026 · Mar 31, 2026 −$4.2M
Net Income Q1 2026 · Mar 31, 2025 −$28.2M
Operating Income Q1 2026 · Mar 31, 2026 −$7.01M
Operating Income Q1 2026 · Mar 31, 2025 −$30.56M